Literature DB >> 25960299

Calciphylaxis: risk factors, diagnosis, and treatment.

Sagar U Nigwekar1, Daniela Kroshinsky2, Rosalynn M Nazarian3, Jeremy Goverman4, Rajeev Malhotra5, Vicki Ann Jackson6, Mihir M Kamdar6, David J R Steele7, Ravi I Thadhani7.   

Abstract

Calciphylaxis is a rare but devastating condition that has continued to challenge the medical community since its early descriptions in the scientific literature many decades ago. It is predominantly seen in patients with chronic kidney failure treated with dialysis (uremic calciphylaxis) but is also described in patients with earlier stages of chronic kidney disease and with normal kidney function. In this review, we discuss the available medical literature regarding risk factors, diagnosis, and treatment of both uremic and nonuremic calciphylaxis. High-quality evidence for the evaluation and management of calciphylaxis is lacking at this time due to its rare incidence and poorly understood pathogenesis and the relative paucity of collaborative research efforts. We hereby provide a summary of recommendations developed by a multidisciplinary team for patients with calciphylaxis.
Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcific uremic arteriolopathy; calciphylaxis; review; risk factors; sodium thiosulfate; warfarin

Mesh:

Substances:

Year:  2015        PMID: 25960299      PMCID: PMC4696752          DOI: 10.1053/j.ajkd.2015.01.034

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  132 in total

1.  Successful treatment of calciphylaxis with intravenous sodium thiosulfate.

Authors:  Jeffrey S Cicone; John B Petronis; Carmen D Embert; David A Spector
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

2.  Low-dose tissue plasminogen activator for calciphylaxis.

Authors:  Lindsay D Sewell; Roger H Weenig; Mark D P Davis; Marian T McEvoy; Mark R Pittelkow
Journal:  Arch Dermatol       Date:  2004-09

Review 3.  Symptomatic management of calciphylaxis: a case series and review of the literature.

Authors:  Mark N Polizzotto; Tamsin Bryan; Michael A Ashby; Peter Martin
Journal:  J Pain Symptom Manage       Date:  2006-08       Impact factor: 3.612

Review 4.  Calcific uremic arteriolopathy: advances in pathogenesis and treatment.

Authors:  Natasha M Rogers; David J O Teubner; P Toby H Coates
Journal:  Semin Dial       Date:  2007 Mar-Apr       Impact factor: 3.455

5.  An unusual case of nonhealing leg ulcer in a diabetic patient.

Authors:  Sagar U Nigwekar
Journal:  South Med J       Date:  2007-08       Impact factor: 0.954

Review 6.  Calciphylaxis.

Authors:  Angie T Ng; David H Peng
Journal:  Dermatol Ther       Date:  2011 Mar-Apr       Impact factor: 2.851

7.  Efficacy of sodium thiosulfate for the treatment for calciphylaxis.

Authors:  L Noureddine; M Landis; N Patel; S M Moe
Journal:  Clin Nephrol       Date:  2011-06       Impact factor: 0.975

Review 8.  Fatal childhood calciphylaxis in a 10-year-old and literature review.

Authors:  Jing Feng; Mona Gohara; Rossitza Lazova; Richard J Antaya
Journal:  Pediatr Dermatol       Date:  2006 May-Jun       Impact factor: 1.588

9.  Calciphylaxis in patients on hemodialysis: a prevalence study.

Authors:  M Angelis; L L Wong; S A Myers; L M Wong
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

10.  Adipocyte induced arterial calcification is prevented with sodium thiosulfate.

Authors:  Neal X Chen; Kalisha O'Neill; Nader Kassis Akl; Sharon M Moe
Journal:  Biochem Biophys Res Commun       Date:  2014-05-10       Impact factor: 3.575

View more
  83 in total

1.  Non-uraemic calciphylaxis successfully treated with pamidronate infusion.

Authors:  David H Truong; Marcus M Riedhammer; Kathya Zinszer
Journal:  Int Wound J       Date:  2018-11-04       Impact factor: 3.315

2.  Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis.

Authors:  Sagar U Nigwekar; Donald B Bloch; Rosalynn M Nazarian; Cees Vermeer; Sarah L Booth; Dihua Xu; Ravi I Thadhani; Rajeev Malhotra
Journal:  J Am Soc Nephrol       Date:  2017-01-03       Impact factor: 10.121

3.  Removing the problem: parathyroidectomy for calciphylaxis.

Authors:  Mohamed Hassanein; Heather Laird-Fick; Richa Tikaria; Saleh Aldasouqi
Journal:  BMJ Case Rep       Date:  2018-12-22

4.  Localization, Morphologic Features, and Chemical Composition of Calciphylaxis-Related Skin Deposits in Patients With Calcific Uremic Arteriolopathy.

Authors:  Hester Colboc; Philippe Moguelet; Dominique Bazin; Priscille Carvalho; Anne-Sophie Dillies; Guillaume Chaby; Hervé Maillard; Diane Kottler; Elisa Goujon; Christine Jurus; Marine Panaye; Vincent Frochot; Emmanuel Letavernier; Michel Daudon; Ivan Lucas; Raphaël Weil; Philippe Courville; Jean-Benoit Monfort; François Chasset; Patricia Senet
Journal:  JAMA Dermatol       Date:  2019-07-01       Impact factor: 10.282

5.  Multidisciplinary management of calciphylaxis: a series of 5 patients at a single facility.

Authors:  Tomohiro Saito; Yuuki Mima; Motonori Sugiyama; Nozomi Miyazawa; Ayana Iida; Nobuhiro Kanazawa; Taihei Suzuki; Yasuto Shikida; Toma Hamada; Yukihiro Wada; Masahide Mizobuchi; Hirokazu Honda
Journal:  CEN Case Rep       Date:  2019-12-17

6.  Invited Commentary: Calcinosis cutis and renal disease: an evolving story.

Authors:  Andrew Z Fenves; Daniela Kroshinsky
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

Review 7.  Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation.

Authors:  Austin Hu; Jingbo Niu; Wolfgang C Winkelmayer
Journal:  Semin Nephrol       Date:  2018-11       Impact factor: 5.299

8.  From primordial gas to the medicine cabinet.

Authors:  Andreas Papapetropoulos; John L Wallace; Rui Wang
Journal:  Br J Pharmacol       Date:  2020-02       Impact factor: 8.739

9.  Development of multiorganic calciphylaxis during teriparatide, vitamin D, and calcium treatment.

Authors:  A Monegal; P Peris; M Alsina; J Colmenero; N Guañabens
Journal:  Osteoporos Int       Date:  2016-03-24       Impact factor: 4.507

Review 10.  Chronic dialysis in patients with end-stage renal disease: Relevance to kidney xenotransplantation.

Authors:  Abhijit Jagdale; David K C Cooper; Hayato Iwase; Robert S Gaston
Journal:  Xenotransplantation       Date:  2018-11-20       Impact factor: 3.907

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.